Similar Search Results

Future costs, fixed healthcare budgets, and the decision rules of cost-effectiveness analysis

Baal, Pieter H. M. van; Meltzer, David; Brouwer, Werner … - In: Health economics 25 (2016) 2, pp. 237-248

Persistent link: https://www.econbiz.de/10011541404

When is it too expensive? : cost-effectiveness thresholds and health care decision-making

Brouwer, Werner B. F.; Baal, Pieter H. M. van; Exel, N. … - In: The European journal of health economics : HEPAC ; … 20 (2019) 2, pp. 175-180

Persistent link: https://www.econbiz.de/10012004796

Thinking rigorously about future costs in cost effectiveness analysis

Lee, Robert H. - In: Journal of health economics 27 (2008) 6, pp. 1650-1651

Persistent link: https://www.econbiz.de/10003802479

Time and time costs in economic evaluation : taking a societal perspective

Brouwer, Werner B. F. - 1999

Persistent link: https://www.econbiz.de/10001495887

Coverage with evidence development for medical devices in Europe : can practice meet theory?

Drummond, Michael F.; Federici, Carlo; Reckers-Droog, Vivian - In: Health economics 31 (2022), pp. 179-194

Persistent link: https://www.econbiz.de/10013433353

Targeted screening for Coeliac Disease among irritable bowel syndrome patients : analysis of cost-effectiveness and value of information

Mohseninejad, Leyla; Feenstra, Talitha Lisbeth; Horst, … - In: The European journal of health economics : HEPAC ; … 14 (2013) 6, pp. 947-957

Persistent link: https://www.econbiz.de/10010204869

Dealing with missing behavioral endpoints in health promotion research by modeling cognitive parameters in cost-effectiveness analyses of behavioral interventions : a validation st...

Prenger, Rilana; Pieterse, Marcel E.; Braakman-Jansen, … - In: Health economics 25 (2016) 1, pp. 24-39

Persistent link: https://www.econbiz.de/10011540508

Targeted screening for Coeliac Disease among irritable bowel syndrome patients: analysis of cost-effectiveness and value of information

Mohseninejad, Leyla; Feenstra, Talitha; Horst, Henriëtte; … - In: The European Journal of Health Economics 14 (2013) 6, pp. 947-957

Screening patients with IBS-D or IBS-mix for CD is almost certainly cost-effective. The screening program would improve the quality of life of those patients with IBS symptoms who actually have CD at a relatively low cost. </AbstractSection> Copyright Springer-Verlag Berlin Heidelberg 2013

Persistent link: https://www.econbiz.de/10010993929

On the economic foundations of CEA : ladies and gentlemen, take your positions!

Brouwer, Werner B. F.; Koopmanschap, Marcus A. - In: Journal of health economics 19 (2000) 4, pp. 439-459

Persistent link: https://www.econbiz.de/10001511471